ampelopsin has been researched along with Hyperglycemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, P; Mi, M; Yao, Y; Yi, L; Yue, J; Zhang, Q; Zhou, J | 1 |
| Ahmed, AF; Amin, AH; Awad, EM; El-Daly, M; El-Tahawy, NFG; Hollenberg, MD; Taye, A; Wagdy, A | 1 |
| Cao, Z; Wang, Z; Yang, Z; Yue, Z | 1 |
| Hu, K; Jiang, B; Le, L; Wan, W; Xiao, P; Xu, L; Zhai, W | 1 |
| Lang, H; Liu, L; Mi, M; Si, M; Wan, J; Zhou, Y; Zhu, J | 1 |
1 review(s) available for ampelopsin and Hyperglycemia
| Article | Year |
|---|---|
Research progress of dihydromyricetin in the treatment of diabetes mellitus.
Topics: Diabetes Mellitus; Flavonols; Humans; Hyperglycemia; Phosphatidylinositol 3-Kinases | 2023 |
4 other study(ies) available for ampelopsin and Hyperglycemia
| Article | Year |
|---|---|
Dihydromyricetin Improves High-Fat Diet-Induced Hyperglycemia through ILC3 Activation via a SIRT3-Dependent Mechanism.
Topics: Animals; Diet, High-Fat; Flavonols; Hyperglycemia; Immunity, Innate; Insulin Resistance; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Sirtuin 3 | 2022 |
Dihydromyricetin protects against high glucose-induced endothelial dysfunction: Role of HIF-1α/ROR2/NF-κB.
Topics: Acetylcholine; Animals; bcl-2-Associated X Protein; Caspase 3; Female; Flavonols; Glucose; Glucose Transporter Type 1; Hyperglycemia; Hypoxia-Inducible Factor 1, alpha Subunit; NF-kappa B; Rats; Receptor Tyrosine Kinase-like Orphan Receptors; Tumor Necrosis Factor-alpha; Vascular Diseases | 2022 |
Metabolomics reveals the protective of Dihydromyricetin on glucose homeostasis by enhancing insulin sensitivity.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Citric Acid Cycle; Diet, High-Fat; Flavonols; Glucose; Glycogen Synthase Kinase 3 beta; Hep G2 Cells; Humans; Hyperglycemia; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; Metabolic Networks and Pathways; Protective Agents; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction; Up-Regulation | 2016 |
Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Flavonols; Hyperglycemia; Insulin Resistance; Male; Obesity; Rats; Rats, Zucker; Time Factors; Weight Gain | 2017 |